HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maddalena Barba Selected Research

Male Breast Neoplasms (Male Breast Cancer)

10/2016HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
11/2015Androgen receptor and antiandrogen therapy in male breast cancer.
5/2015Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis.
3/2015Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study.
11/2014Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
9/2014Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.
8/2013Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maddalena Barba Research Topics

Disease

76Neoplasms (Cancer)
12/2021 - 01/2005
45Breast Neoplasms (Breast Cancer)
01/2021 - 01/2005
28Hemorrhage
12/2021 - 05/2008
20Venous Thromboembolism
12/2021 - 07/2008
12Thrombocytopenia (Thrombopenia)
11/2018 - 06/2008
9Triple Negative Breast Neoplasms
01/2021 - 12/2015
7Venous Thrombosis (Deep-Vein Thrombosis)
11/2018 - 06/2008
7Male Breast Neoplasms (Male Breast Cancer)
10/2016 - 08/2013
5Pulmonary Embolism
10/2021 - 11/2011
5Thrombosis (Thrombus)
01/2018 - 06/2008
4Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2021 - 01/2014
4Disease Progression
09/2019 - 08/2013
4Neoplasm Metastasis (Metastasis)
01/2019 - 05/2013
4Stomach Neoplasms (Stomach Cancer)
01/2018 - 09/2013
4Infections
10/2014 - 06/2008
3Hematoma
11/2018 - 11/2011
3Wounds and Injuries (Trauma)
11/2018 - 11/2011
3Prostatic Neoplasms (Prostate Cancer)
10/2009 - 12/2004
2Adenocarcinoma of Lung
12/2021 - 11/2019
2Obesity
11/2020 - 10/2016
2COVID-19
08/2020 - 01/2020
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2019 - 01/2019
2Ovarian Neoplasms (Ovarian Cancer)
02/2018 - 08/2013
2Rare Diseases (Rare Disease)
08/2017 - 11/2014
2Ovarian Epithelial Carcinoma
01/2016 - 08/2013
1Vulvar Neoplasms (Vulvar Cancer)
08/2021
1Multiple Myeloma
01/2021
1Thromboembolism
01/2021

Drug/Important Bio-Agent (IBA)

26AnticoagulantsIBA
12/2021 - 07/2008
23Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2021 - 05/2008
22Heparin (Liquaemin)FDA LinkGeneric
12/2021 - 05/2008
16Vitamin KFDA Link
10/2021 - 06/2008
15Hormones (Hormone)IBA
07/2020 - 01/2005
13Fondaparinux (Arixtra)FDA Link
12/2021 - 05/2008
11Biomarkers (Surrogate Marker)IBA
07/2021 - 10/2014
9Trastuzumab (Herceptin)FDA Link
12/2020 - 05/2013
8Phenobarbital (Luminal)FDA Link
01/2021 - 01/2013
6Immune Checkpoint InhibitorsIBA
12/2021 - 12/2018
6pertuzumabIBA
01/2021 - 01/2017
6Taxoids (Taxanes)IBA
09/2020 - 05/2013
6AnthracyclinesIBA
09/2020 - 05/2013
6Glucose (Dextrose)FDA LinkGeneric
02/2018 - 01/2005
5Biological ProductsIBA
08/2021 - 01/2014
5human ERBB2 proteinIBA
01/2021 - 10/2014
5Estrogen ReceptorsIBA
09/2019 - 10/2014
5Warfarin (Coumadin)FDA LinkGeneric
07/2014 - 12/2010
4eribulinFDA Link
01/2021 - 05/2016
4Phosphotransferases (Kinase)IBA
11/2019 - 01/2016
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2015 - 08/2013
4ximelagatran (Exanta)IBA
07/2014 - 06/2008
3DNA (Deoxyribonucleic Acid)IBA
04/2021 - 12/2015
3Ado-Trastuzumab EmtansineIBA
01/2021 - 01/2017
3EverolimusFDA Link
07/2020 - 01/2017
3exemestane (Aromasin)FDA Link
07/2020 - 01/2017
3Capecitabine (Xeloda)FDA Link
09/2019 - 05/2013
3Bevacizumab (Avastin)FDA Link
01/2019 - 06/2017
3Androgen Antagonists (Antiandrogens)IBA
11/2015 - 11/2014
3Aromatase InhibitorsIBA
05/2015 - 08/2013
3Metformin (Glucophage)FDA LinkGeneric
05/2015 - 08/2009
3Estrogens (Estrogen)FDA Link
10/2014 - 10/2009
2Tinzaparin (Innohep)FDA Link
12/2021 - 01/2018
2Dalteparin (Dalteparin Sodium)FDA Link
12/2021 - 01/2018
2cyclo(Arg-Pro) (CI 4)IBA
10/2021 - 11/2018
2Pharmaceutical PreparationsIBA
01/2021 - 03/2015
2Indicators and Reagents (Reagents)IBA
11/2020 - 01/2016
2Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2019
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2014
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 02/2015
2CI 22IBA
11/2018 - 01/2018
2Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 06/2017
2idraparinuxIBA
01/2018 - 07/2014
2Fulvestrant (Faslodex)FDA Link
09/2017 - 08/2017
2Oncogene Proteins (Oncogene Protein)IBA
06/2016 - 01/2016
2PlatinumIBA
01/2016 - 08/2013
2Androgen Receptors (Androgen Receptor)IBA
11/2015 - 11/2014
2Cyproterone AcetateIBA
05/2015 - 11/2014
2Progesterone Receptors (Progesterone Receptor)IBA
10/2014 - 10/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2014 - 08/2013
2Docetaxel (Taxotere)FDA Link
10/2014 - 09/2013
2apixabanIBA
07/2014 - 06/2014
1GenieIBA
12/2021
1Lenalidomide (CC 5013)FDA Link
01/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021
1Immunomodulating AgentsIBA
01/2021
1GlucocorticoidsIBA
01/2021
1Thalidomide (Thalomid)FDA Link
01/2021
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1pomalidomideIBA
01/2021
1LigandsIBA
09/2020

Therapy/Procedure

37Therapeutics
12/2021 - 01/2005
20Drug Therapy (Chemotherapy)
10/2021 - 09/2013
11Neoadjuvant Therapy
01/2021 - 10/2014
6Immunotherapy
12/2021 - 11/2017
5Radiotherapy
10/2021 - 12/2014
5Central Venous Catheters
01/2018 - 06/2008
4Treatment Delay
01/2018 - 02/2011
2Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 10/2014
1Drug Tapering
01/2021